posted on 2020-04-27, 14:15authored byChaomin Li, Lloyd Franklin, Robbie Chen, Tamera Mack, Michael Humora, Bin Ma, Brian T. Hopkins, John Guzowski, Fengmei Zheng, Michael MacPhee, Yiqing Lin, Steven Ferguson, Daniel Patience, George A. Moniz, William F. Kiesman, Erin M. O’Brien
Chemical process development efforts
leading to multikilogram production
of BIIB068 hemiadipate are discussed. Process optimization resulted
in (1) removal of transition metal from the process, (2) a streamlined
process with significantly improved overall yield, and (3) appropriate
impurity control (including potential mutagenic impurities), which
enabled delivery of quality material for toxicology studies and clinical
trials.